
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vertex Pharmaceuticals (United Kingdom), United Kingdom, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
47%
Total
Publications
222
Total Open
Publications
104
Total
Citations
8.6K
Open Access
Percentage
47%
Total
Publications
222
Total Open
Publications
104
Total
Citations
8.6K
Breakdown
Publisher Open
14%
Both
25%
Other Platform Open
5%
Closed
56%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 46%
39
Hybrid 37%
31
No Guarantees 17%
14
Other Platform Open
Domain 79%
52
Institution 32%
21
Other Internet 15%
10
Public 6%
4
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 52 |
DOI | Other Internet | 10 |
Europe PMC | Domain | 5 |
Imperial College London - Spiral | Institution | 4 |
Figshare | Public | 4 |
University of Nottingham - Repository@Nottingham | Institution | 3 |
ORA - Oxford University Research Archive | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |
University of Potsdam - publish.UP | Institution | 1 |